Trambauer J, Sarmiento R, Garringer H, Salbaum K, Pedro L, Crusius D
Alzheimers Res Ther. 2025; 17(1):49.
PMID: 39972463
PMC: 11837686.
DOI: 10.1186/s13195-025-01680-3.
Guichardaz M, Bottini S, Balmas E, Bertero A
Open Res Eur. 2025; 4:266.
PMID: 39926351
PMC: 11803382.
DOI: 10.12688/openreseurope.19024.1.
Hamer M, Rossi F
Front Cell Dev Biol. 2025; 12:1526635.
PMID: 39911186
PMC: 11794491.
DOI: 10.3389/fcell.2024.1526635.
Rath P, Kramer P, Biggs D, Preece C, Hortin N, Diaz R
Stem Cells. 2025; 43(1).
PMID: 39777513
PMC: 11740728.
DOI: 10.1093/stmcls/sxae092.
Wang L, Xu W, Zhang S, Gundberg G, Zheng C, Wan Z
Nat Biomed Eng. 2024; 8(12):1730-1743.
PMID: 38982158
DOI: 10.1038/s41551-024-01229-z.
Elevated α-synuclein levels inhibit mitophagic flux.
Kinnart I, Manders L, Heyninck T, Imberechts D, Praschberger R, Schoovaerts N
NPJ Parkinsons Dis. 2024; 10(1):80.
PMID: 38594264
PMC: 11004019.
DOI: 10.1038/s41531-024-00696-0.
Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium.
Karbassi E, Padgett R, Bertero A, Reinecke H, Klaiman J, Yang X
Cell Mol Life Sci. 2024; 81(1):95.
PMID: 38372898
PMC: 10876724.
DOI: 10.1007/s00018-023-05101-2.
Engineering human pluripotent stem cell lines to evade xenogeneic transplantation barriers.
Pizzato H, Alonso-Guallart P, Woods J, Connelly J, Fehniger T, Atkinson J
Stem Cell Reports. 2024; 19(2):299-313.
PMID: 38215755
PMC: 10874864.
DOI: 10.1016/j.stemcr.2023.12.003.
Disruption of MAM integrity in mutant FUS oligodendroglial progenitors from hiPSCs.
Zhu Y, Burg T, Neyrinck K, Vervliet T, Nami F, Vervoort E
Acta Neuropathol. 2024; 147(1):6.
PMID: 38170217
PMC: 10764485.
DOI: 10.1007/s00401-023-02666-x.
Computationally defined and in vitro validated putative genomic safe harbour loci for transgene expression in human cells.
Autio M, Motakis E, Perrin A, Bin Amin T, Tiang Z, Do D
Elife. 2024; 13.
PMID: 38164941
PMC: 10836832.
DOI: 10.7554/eLife.79592.
Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a "Trojan Horse".
Karpov D, Sosnovtseva A, Pylina S, Bastrich A, Petrova D, Kovalev M
Int J Mol Sci. 2023; 24(24).
PMID: 38139149
PMC: 10743607.
DOI: 10.3390/ijms242417320.
Osmolar Modulation Drives Reversible Cell Cycle Exit and Human Pluripotent Cell Differentiation via NF-κВ and WNT Signaling.
Chui J, Izuel-Idoype T, Qualizza A, de Almeida R, Piessens L, van der Veer B
Adv Sci (Weinh). 2023; 11(7):e2307554.
PMID: 38037844
PMC: 10870039.
DOI: 10.1002/advs.202307554.
Spatially Self-Organized Three-Dimensional Neural Concentroid as a Novel Reductionist Humanized Model to Study Neurovascular Development.
Chai Y, To S, Simorgh S, Zaunz S, Zhu Y, Ahuja K
Adv Sci (Weinh). 2023; 11(5):e2304421.
PMID: 38037510
PMC: 10837345.
DOI: 10.1002/advs.202304421.
Production of therapeutic levels of human FIX-R338L by engineered B cells using GMP-compatible medium.
David M, Monteferrario D, Saviane G, Jeanneau C, Marchetti I, Dupont C
Mol Ther Methods Clin Dev. 2023; 31:101111.
PMID: 37790246
PMC: 10543988.
DOI: 10.1016/j.omtm.2023.101111.
Uniform transgene activation in Tet-On systems depends on sustained rtTA expression.
Otomo J, Woltjen K, Sakurai H
iScience. 2023; 26(10):107685.
PMID: 37701566
PMC: 10494183.
DOI: 10.1016/j.isci.2023.107685.
Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies.
Dabiri H, Safarzadeh Kozani P, Habibi Anbouhi M, Mirzaee Godarzee M, Haddadi M, Basiri M
Biomark Res. 2023; 11(1):67.
PMID: 37403182
PMC: 10318782.
DOI: 10.1186/s40364-023-00509-1.
Integrating Omics and CRISPR Technology for Identification and Verification of Genomic Safe Harbor Loci in the Chicken Genome.
Dehdilani N, Goshayeshi L, Yousefi Taemeh S, Bahrami A, Rival Gervier S, Pain B
Biol Proced Online. 2023; 25(1):18.
PMID: 37355580
PMC: 10290409.
DOI: 10.1186/s12575-023-00210-5.
Tetracycline-Inducible and Reversible Stable Gene Expression in Human iPSC-Derived Neural Progenitors and in the Postnatal Mouse Brain.
Linesch P, Akhtar A, Breunig J
Curr Protoc. 2023; 3(6):e792.
PMID: 37283517
PMC: 10264152.
DOI: 10.1002/cpz1.792.
Understanding neural development and diseases using CRISPR screens in human pluripotent stem cell-derived cultures.
Ahmed M, Muffat J, Li Y
Front Cell Dev Biol. 2023; 11:1158373.
PMID: 37101616
PMC: 10123288.
DOI: 10.3389/fcell.2023.1158373.
A large-scale functional analysis of genes expressed differentially in insulin secreting MIN6 sublines with high versus mildly reduced glucose-responsiveness.
Tanaka A, Kosuda M, Yamana M, Furukawa A, Nagasawa A, Fujishiro M
Sci Rep. 2023; 13(1):5654.
PMID: 37024560
PMC: 10079668.
DOI: 10.1038/s41598-023-32589-2.